Rare disease focus Target Rare Genomics Institute as a partner for expanding access to genetic sequencing services and research collaboration, highlighting their mission to diagnose and treat undiagnosed rare diseases and their advocacy activities.

Strategic partnerships Leverage past collaborations with DanteLabs, Genomenon, and PacBio integration to propose scalable sequencing, data analysis, and international network expansion opportunities that align with RG's iHope framework.

Tech stack leverage Offer solutions that integrate with RG’s existing cloud and AI infrastructure (AWS, Azure, SageMaker, Hugging Face) to enhance sequencing data processing, analytics, and patient matching workflows.

Funding and impact Position opportunities around grant-driven programs and donor engagement to support RG’s RareWear initiatives and annual grant competitions, aligning with their non profit model and community-building efforts.

Growth potential With revenue in the low to mid seven figures and a lean team, present scalable, high-impact services and partnerships that can accelerate diagnostics, data curation, and international referrals without significant headcount growth.